Mangalam Drugs And Organics Limited Stock: price and insider trades · India

Mangalam Drugs And Organics Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). 7 insiders have disclosed 10 filings since 24 October 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

For context, the typical company on the same exchange (median of 1,985 companies) published 4 filings over the same period, against 10 filings here. Over the whole record (from 2021), the tally stands at 6 purchases and 3 sales.

Over the last twelve months, not one insider purchase of Mangalam Drugs And Organics Limited stock was filed. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 5 days. That lag is the time during which only the insider knows about the trade.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.